A recent study offering a comprehensive view of the genome and transcriptome of gastrointestinal stromal tumors (GISTs) has introduced a new, multi-omics-based molecular classification of these tumors ...

GISTs originate from interstitial cells of Cajal and are staged by size, location, mitotic rate, and genetic mutations, influencing treatment strategies. Diagnosis involves imaging, endoscopy, biopsy, ...

Colonic schwannomas are rare, generally benign tumours that originate from Schwann cells in the neural sheath. They are often identified incidentally as submucosal masses during routine colonoscopy ...

Gastrointestinal stromal tumors (GISTs) represent a rare tumor entity that occurs in the muscular layer of the digestive tract. These tumors commonly metastasize to the liver and peritoneum, and ...

Patients with GIST have more treatment options than ever, with others currently under development. On a summer Sunday in 2011, Lee Keenan competed in the Pleasant Prairie Triathlon in Wisconsin. At 42 ...

Gastrointestinal stromal tumors (GISTs) are growths that form in the digestive tract. The overall GIST survival rate for 5 years is 85%. However, this rate cannot predict the survival of any ...

A tumor is a mass of abnormal tissue caused by an overgrowth of cells. Benign tumors don’t always require treatment, but they do call for careful monitoring. There are two main types of tumors. Benign ...

All cancers are tumors, but not all tumors are cancers. Tumors can either be benign (non-cancerous) or malignant (cancerous). The first type, that is benign tumours do not spread to other parts of the ...

If you have advanced gastrointestinal stromal tumor (GIST), you may not know anyone else with the disease. This may leave you with a lot of questions about what life will be like with this rare cancer ...